UBS Downgrades Rivian to Sell
UBS analyst Joseph Spak downgraded on January 14, 2026, Rivian from ‘Neutral’ to ‘Sell’ with a price target of $15 (from $13).
“We downgrade RIVN to Sell, $15 PT seeing a less favorable risk/reward.
RIVN stock has been prone to sentiment swings (often driving stock more than fundamentals) and the stock is +15% since Autonomy and AI Day on Dec.
11 (vs. S&P500 +1%) as the market assigned more enthusiasm to their AI potential.
However, in our view, most of the AI related news is “out”.
The other point of enthusiasm is the launch of the R2 and while we like the vehicle, expectations may be too high; our 2026/27 sales forecast is 16/19% below consensus, and current stock prices in ’27 sales ~25% above UBSe.
We see ~20% downside in our base case ($15 PT) and a ~1.6x downside to upside negative skew.”
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.
This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.
